临床外科杂志 ›› 2024, Vol. 32 ›› Issue (1): 62-66.doi: 10.3969/j.issn.1005-6483.2024.01.017

• 论著 • 上一篇    下一篇

经肛门直肠黏膜瓣推移术与经肛括约肌间切开术治疗复杂性肛瘘的效果及对肛管直肠压力的影响

  

  1. 443000 湖北宜昌,三峡大学第三临床医学院·国药葛洲坝中心医院普外科(熊健、谢华辉、沈明、张仁浩、牛天峰、罗靖);湖北省荆州市中医医院普外科(何文涛、李明堃)
  • 收稿日期:2023-03-11 接受日期:2023-03-11 出版日期:2024-01-20 发布日期:2024-01-20
  • 通讯作者: 通信作者:谢华辉,Email:422375615@qq.com

Effect of transanal mucosal flap displacement and transanal intersphincterotomy on the treatment of complex anal fistulas and their influence on the pressure of anorectal canal

  1. Department of General Surgery,Chinese Medicine Gezhouba Central Hospital,Hubei,Yichang 443000,China
  • Received:2023-03-11 Accepted:2023-03-11 Online:2024-01-20 Published:2024-01-20

摘要: 目的   探讨经肛门直肠黏膜瓣推移术(endoanal advancement flap,ERAF)与经肛括约肌间切开术(transanal opening of intersphincteric space,TROPIS)治疗复杂性肛瘘的效果及对肛管直肠压力的影响。方法   2018年10月~2022年10月收治的复杂性肛瘘病人84例,按治疗方法分为ERAF治疗组(E组,48例)和TROPIS治疗组(T组,36例)。比较两组临床疗效、手术情况、创面情况以及肛管直肠压力。 结果   T组治疗有效率为97.22%,高于E组的87.50%,但差异无统计学意义(P>0.05)。T组手术时间为(31.53±7.29)分钟,术中出血量为(29.56±7.37)ml,手术当天、术后7天和14天创面面积分别为(10.03±0.96)cm2、(8.76±0.87)cm2和(6.20±0.77)cm2,E组分别为(35.36±8.54)分钟、(36.86±8.04)ml、(12.09±1.23)cm2、(10.52±1.09)cm2和(7.36±0.85)cm2,两组比较差异有统计学意义(P<0.05)。T组术后VAS评分、Wexner失禁评分分别为(1.38±0.27)分和(0.21±0.08)分,E组分别为(1.56±0.29)分和(0.33±0.09)分,T组20mm处、30mm处肛管直肠收缩压和20mm处、30mm处肛管直肠静息压分别为(138.18±29.58)mmHg、(136.22±35.41)mmHg、(35.47±6.58)mmHg和(32.97±8.01)mmHg,E组分别为(152.78±31.53)mmHg、(156.29±32.74)mmHg、(38.29±7.62)mmHg、(36.41±7.63)mmHg,两组评分和肛管直肠压力均下降,且T组低于E组,两组比较差异有统计学意义(P<0.05)。E组不良反应发生率(20.83%)高于F组的(13.89%),但差异无统计学意义(P>0.05)。 结论   TROPIS治疗复杂性肛瘘的效果更好,能缩减手术时间,减少术中出血量,减轻术后疼痛,保护肛门功能。

关键词: 经肛门直肠黏膜瓣推移术, 经肛括约肌间切开术, 复杂性肛瘘, 直肠, 肛管

Abstract: Objective   To explore the effect of Endoanal advancement flap (ERAF) and transanal opening of interphincteric space (TROPIS) in the treatment of complex anal fistula and their impact on anorectal pressure,so as to provide a reference for clinical selection of surgical methods.Methods   Eighty-four patients with complex anal fistula admitted from October 2018 to October 2022 were divided into group E received ERAF treatment (n=48) and group T received TROPIS treatment (n=36).The clinical efficacy,operation,wound surface and anorectal pressure of the two groups were compared.Results   The effective rate of treatment in Group T was 97.22%,which was higher than that in Group E(87.50%),with no statistically significant difference (P>0.05).The surgical time [(31.53±7.29) minutes],intraoperative bleeding volume [(29.56±7.37) ml],and wound area [(10.03±0.96) cm2,(8.76±0.87) cm2,(6.20±0.77) cm2] on the day of surgery,7 and 14 days after surgery in Group T were all smaller than those in Group E[(35.36±8.54)min,(36.86±8.04)ml,(12.09±1.23)cm2,(10.52±1.09)cm2 and(7.36±0.85)cm2] (P<0.05).After surgery,the VAS score and Wexner incontinence score of Group T were (1.38±0.27) and (0.21±0.08),respectively.Group E was (1.56±0.29) and (0.33±0.09),respectively.In group T, the anorectal systolic pressure at 20mm and 30mm and the anorectal resting pressure at 20mm and 30mm were(138.18±29.58) mmHg,(136.22±35.41) mmHg,(35.47±6.58) mmHg,and (32.97±8.01) mmHg,respectively.In Group E, the data was (152.78±31.53) mmHg,(156.29±32.74) mmHg,(38.29±7.62) mmHg and (36.41±7.63) mmHg,respectively.Both groups showed a decrease in score and anorectal pressure,and group T was lower than group E (P<0.05).The incidence of adverse reactions in Group E was 20.83% ,which was higher than that in Group T(11.11%),but the difference was not statistically significant (P>0.05).Conclusion   TROPIS has a better effect in the treatment of complex anal fistula,which can shorten the operation time,reduce intraoperative bleeding,reduce postoperative pain,and protect anal function.

Key words: endoanal advancement flap, transanal opening of intersphincteric space, complex anal fistula, rectum, anal canal

[1] 张荣欣 米思源 廖俊毅 康达 陈功. 美国国立综合癌症网络直肠癌临床实践指南(2023.V1-V5)更新解读[J]. 临床外科杂志, 2024, 32(1): 37-40.
[2] 付锦程 付涛. 泛素特异性蛋白酶7功能和在结直肠癌中的研究进展[J]. 临床外科杂志, 2024, 32(1): 106-109.
[3] 乔玥玥 刘淑桢 张坤. 直肠恶性肿瘤伴肝包虫病一例[J]. 临床外科杂志, 2023, 31(9): 842-843.
[4] 曾新宇 李源 王点石 沈楚 郭熙恺 吕剑波 陶凯雄 吴川清. 根治术后行肠造口的结直肠癌病人行腹腔热灌注化疗的可行性和安全性分析[J]. 临床外科杂志, 2023, 31(8): 742-746.
[5] 梁林虎 张峥嵘 李浩然 程正武 江厚象. 结直肠癌切除术病人嗜神经侵袭情况及其与预后的相关性研究[J]. 临床外科杂志, 2023, 31(8): 773-777.
[6] 吴海燕 邵泽生 崔恒锋. 结直肠癌病人白蛋白、碱性磷酸酶水平对腹腔镜根治术后淋巴结转移的预测[J]. 临床外科杂志, 2023, 31(7): 654-658.
[7] 孔德建 李帅 曹国庆 张茜 罗智彬 汤绍涛. 腹腔镜或机器人辅助Duhamel拖出术后留置肛管时间对巨结肠患儿术后恢复的影响[J]. 临床外科杂志, 2023, 31(7): 690-693.
[8] 刘智敏 任东林. 复杂性肛瘘诊疗中的挑战与展望[J]. 临床外科杂志, 2023, 31(6): 501-505.
[9] 李璐 孙桂东 邵万金. 骶前肿瘤的诊疗策略[J]. 临床外科杂志, 2023, 31(6): 509-513.
[10] 李晓和 杨胜富 粟业能 徐绍强 冯广革. 直肠癌会阴切口重建及肠造口关闭术中十字缝合法应用效果及安全性研究[J]. 临床外科杂志, 2023, 31(6): 528-532.
[11] 邓涛 何杰. 改良的完整保留邓氏筋膜的创新直肠系膜切除手术在直肠癌中的应用效果[J]. 临床外科杂志, 2023, 31(6): 533-536.
[12] 赵飞龙 吴文雅 田君 徐晓忠 鲍乐峰. 经自然腔道取标本手术对比传统腹腔镜手术在结直肠癌中的优势性及安全性分析 [J]. 临床外科杂志, 2023, 31(6): 538-541.
[13] 柳万忠 龙煊 邓志刚. 结直肠癌组织转录因子E2F2、黏蛋白样受体2水平与病人临床病理特征的关系及对淋巴结转移的诊断价值[J]. 临床外科杂志, 2023, 31(6): 542-545.
[14] 司宇光 吴国庆 袁成龙. 不同腹部辅助性切口对腹腔镜直肠癌根治术病人肠道功能及生活质量的影响[J]. 临床外科杂志, 2023, 31(4): 353-356.
[15] 胡军 罗俊峰 周文斌 李包根 吕玉良 毛盛勋. 同时性多原发性结直肠癌六例诊治体会[J]. 临床外科杂志, 2023, 31(4): 360-363.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!